Patents by Inventor Ruben Jose CRESPO-DIAZ

Ruben Jose CRESPO-DIAZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
    Publication number: 20220339253
    Abstract: This document provides methods and materials for reducing the risk of major adverse cardiac events. For example, methods and materials for identifying patients at risk of experiencing a major adverse cardiac event as well as methods and material for treating patients at risk of experiencing a major adverse cardiac event (e.g., patients who underwent percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI)) are provided.
    Type: Application
    Filed: July 7, 2022
    Publication date: October 27, 2022
    Inventors: Atta Behfar, Andre Terzic, Ruben Jose Crespo-Diaz
  • Using nucleic acids encoding NAP-2 polypeptides to improve cardiac function
    Patent number: 11413330
    Abstract: This document provides methods and materials for reducing the risk of major adverse cardiac events. For example, methods and materials for identifying patients at risk for experiencing a major adverse cardiac event as well as methods and material for treating patients at risk of experiencing a major adverse cardiac event (e.g., patients who underwent percutaneous coronary intervention (PCT) for ST-elevation myocardial infarction (STEMI) are provided.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: August 16, 2022
    Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Atta Behfar, Andre Terzic, Ruben Jose Crespo-Diaz
  • USING NUCLEIC ACIDS ENCODING NAP-2 AND TGF-ALPHA POLYPEPTIDES TO IMPROVE CARDIAC FUNCTION
    Publication number: 20200353047
    Abstract: This document provides methods and materials for reducing the risk of major adverse cardiac events. For example, methods and materials for identifying patients at risk for experiencing a major adverse cardiac event as well as methods and materials for treating patients at risk of experiencing a major adverse cardiac event (e.g., patients who underwent percutaneous coronary intervention (PCT) for ST-elevation myocardial infarction (STEMI) are provided.
    Type: Application
    Filed: June 3, 2020
    Publication date: November 12, 2020
    Inventors: Atta Behfar, Andre Terzic, Ruben Jose Crespo-Diaz
  • NAP-2 polypeptides and methods for modulating immune system activity in heart tissue
    Patent number: 10682394
    Abstract: This document provides methods and materials for reducing the risk of major adverse cardiac events. For example, methods and materials for identifying patients at risk of experiencing a major adverse cardiac event as well as methods and material for treating patients at risk of experiencing a major adverse cardiac event (e.g., patients who underwent percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) are provided.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: June 16, 2020
    Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Atta Behfar, Andre Terzic, Ruben Jose Crespo-Diaz
  • USING NUCLEIC ACIDS ENCODING NAP-2 AND TGF-ALPHA POLYPEPTIDES TO IMPROVE CARDIAC FUNCTION
    Publication number: 20180214518
    Abstract: This document provides methods and materials for reducing the risk of major adverse cardiac events. For example, methods and materials for identifying patients at risk of experiencing a major adverse cardiac event as well as methods and material for treating patients at risk of experiencing a major adverse cardiac event (e.g., patients who underwent percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) are provided.
    Type: Application
    Filed: December 21, 2017
    Publication date: August 2, 2018
    Inventors: Atta Behfar, Andre Terzic, Ruben Jose Crespo-Diaz
  • Using nucleic acids encoding NAP-2 and TGF-alpha polypeptides to improve cardiac function
    Patent number: 9884090
    Abstract: This document provides methods and materials for reducing the risk of major adverse cardiac events. For example, methods and materials for identifying patients at risk of experiencing a major adverse cardiac event as well as methods and material for treating patients at risk of experiencing a major adverse cardiac event (e.g., patients who underwent percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI)) are provided.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: February 6, 2018
    Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Atta Behfar, Andre Terzic, Ruben Jose Crespo-Diaz
  • REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
    Publication number: 20160206697
    Abstract: This document provides methods and materials for reducing the risk of major adverse cardiac events. For example, methods and materials for identifying patients at risk of experiencing a major adverse cardiac event as well as methods and material for treating patients at risk of experiencing a major adverse cardiac event (e.g., patients who underwent percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI)) are provided.
    Type: Application
    Filed: September 3, 2014
    Publication date: July 21, 2016
    Inventors: Atta BEHFAR, Andre TERZIC, Ruben Jose CRESPO-DIAZ